View
10
Download
2
Category
Preview:
DESCRIPTION
Antidiabetic Drugs
Citation preview
Antidiabetic Drugs
Dr Nagwa Nour EL DinAssistant Professor
Pharmacology
Diabetes Mellitus• Chronic disorder of carbohydrate metabolism• Results from inadequate production or
underutilization of insulin• Type 1: onset during childhood autoimmune
destruction of pancreatic B cells. • Type 2:increasing insulin resistance and
diminishing insulin secretory capacity. frequently associated with obesity and is much more common. usually has its onset in adulthood
Diabetes Mellitus
• Symptoms: Hyperglycemia (Fasting blood glucose 126mg/dl)glucosuria, polyuria, polydipsia and polyphagia.• Without intervention, significant complications
retinopathies, glaucoma, neuropathies, cardiovascular disease.PVD.
Anti-diabetic drugs • Insulin• Oral antidiabetic drugs
Effects of insulin (anabolic hormone)
• Decrease blood glucose level by:– Increase glucose uptake by muscle and adipose tissues – Increase glucose utilization – Increase glucose storage as glycogen in liver & muscle and inhibit glycogen
breakdown
• Increase lipid formation (lipogenesis )and inhibit lipid breakdown (lipolysis)
• Increase amino acid entry into the muscle and protein synthesis
Insulin Preparations Rapid-Actinginsulin lispro, insulin aspart, have rapid onsets and early peaks of activity that permit control of postprandial glucose levels. They are injected immediately before a meal. Short-ActingRegular insulin is used IV in emergencies or sc in maintenance regimens, alone or mixed with intermediate- or long-acting preparations. it requires administration 1 h or more before a meal. Intermediate-ActingNPH insulin exhibits a delayed onset and peak of action is often combined with regular and rapid-acting insulins. Long-ActingInsulin glargine provide a peakless basal insulin level lasting more than 20 h, which helps control basal glucose levels without producing hypoglycemia.
1 2 3 4 5 6 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Time (h)
Extent & duration of action of various types of insulin
Insulin lispro
Regular insulin
NPH insulinUltralente insulin
Insulin glargine
Up to 24hrs8-12hrs2hrsIntermediate –actingNPH Insulin
≥24hrs Peakless2hrsLong- actingInsulin glargine
8hrs2-4hrs30-45 minShort -acting Regular insulin
< 5hrs1 hr5-10min
Rapid acting1. Insulin Lispro2. Insulin aspart
Duration PeakOnset
0.6-0.7U/Kg/dayIn obese
2U/Kg/day
The daily dose of insulin includes:
WE use mixtures of Intermediate or long acting insulin to cover basal body needs
Regular, lispro or aspart insulin is added :1. They permit control of postprandial glucose levels2. Intermediate & long acting insulin require several hours to reach peak
therapeutic level
The most common regimen for insulin administration Split –mixed regimen
Involves the pre-breakfast(2/3dose) and pre-supper (1/3 dose) injection of a mixture of regular and intermediate acting insulin
Basal bolus regimen : rapid before meals + long acting once
Hazards of insulin use
1.Hypoglycemia
A. Excessive insulin effects
Conscious patients Sugar or candy by mouth
Unconscious patient: • IV infusion of 50ml of
50%glucose • Or Glucagon IM
2. Overeating & obesity
Tachycardia, sweating,Hunger pain, confusion, convulsion
and coma
B. Lipodystrophy at injection site
Indication for the use of insulin therapy
1. Patient with type I DM2. Pregnant women who already have
type II DM or acquire gestational diabetes during their pregnancy
3. Patients who have type II DM and require
intermittent insulin administration , such as during surgery or infection4. Ketoacidosis
Oral anti-diabetic drugsUsed for treatment of type II DM
Oral antidiabetics
Sulphonylureas
Secretogogues
Biguanides
endogenous glucose
production
Glitazones
tissue Sensitivity to
insulin
Acrabose
Slowing rate of Glucose
Absorption from GIT
1- Sulfonylureas• insulin release from pancreatic beta cells• 1st generation• 2nd generation Glyburide Glipizide Adverse effects:1- Hypoglycemia 2- ↑ appetite →↑body weight
2- Biguanides
Metformin1. hepatic Gluconeogenesis2. glucose uptake & oxidation3. glucose absorption from GIT4. plasma glucagon level Adverse effects: GIT distress
Biguanides Sulphonylureas
Metformin ↓endogenous G
productionNo (euglycemic)
↓
Obese type 2 diabetesGIT disturbances
Glyburide↑ release of
insulin
Yes
↑
Type 2 diabetesHypoglycemia-↑appetite
Example Mechanism
Risk of hypoglycemia
Appetite & weight
Use Adverse effects
3- Glitazones (Thiazolidinediones)
• Pioglitazone Mechanism of actionIncrease the sensitivity of liver, skeletal muscle & adipose tissue to insulin Adverse effects1. Fluid retention & Edema 2. Anemia3. CV risk (rosiglitazone)
4- Acarbose Glucosidase inhibitor act in the intestine • Slow digestion of starch & Delay absorption
of glucose so postprandial hyperglycemia is reduced No hypoglycemia
Complex-CHO
Glucose
glucosidase
Absorption
Adverse effects GIT distress : Flatulence and diarrhea
Glitazones
Sites of action of oral hypoglycemics
Recommended